Paratek Pharmaceuticals (NASDAQ:PRTK) Downgraded by StockNew

StockNews.com downgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a buy rating to a hold rating in a report issued on Saturday. Other equities research analysts have also recently issued reports about the company. HC Wainwright lowered their target price on Paratek Pharmaceuticals from $10.00 to $6.00 in a research note on Wednesday, […]

Related Keywords

Jamesd Dondero , , Carlyle Group Inc , News Ratings For Paratek Pharmaceuticals Daily , Kathmere Capital Management , Cm Management , Paratek Pharmaceuticals Trading Down , Paratek Pharmaceuticals Company Profile , Paratek Pharmaceuticals Inc , Arete Wealth Advisors , Cutter Co Brokerage Inc , Insider Activity At Paratek Pharmaceuticals , Securities Exchange Commission , Paratek Pharmaceuticals , Get Rating , Pharmaceuticals Trading Down , Exchange Commission , Wealth Advisors , Capital Management , Carlyle Group , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Prtk , Medical , 89354m10 , Downgrade , Stocknews Com ,